AHA-BUCH

Principles of Anticancer Drug Development
-12 %

Principles of Anticancer Drug Development

 Buch
Sofort lieferbar | Lieferzeit:3-5 Tage I

Unser bisheriger Preis:ORGPRICE: 213,99 €

Jetzt 188,31 €*

Alle Preise inkl. MwSt. | zzgl. Versand
ISBN-13:
9781441973573
Einband:
Buch
Erscheinungsdatum:
01.12.2010
Seiten:
673
Autor:
Elizabeth Garrett-Mayer
Gewicht:
1150 g
Format:
259x168x43 mm
Serie:
Cancer Drug Discovery and Development
Sprache:
Englisch
Beschreibung:

This book takes a look at: Basic Biostatistics for the Clinical Trialist, Fundamental Concepts in Clinical Pharmacology, Analytical Methods in Drug Development, and Preclinical Efficacy Evaluation of Anticancer Agents.

It is a practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

Additionally, Clinical Trials with Anticancer Agents are reviewed, and many other topics in the area of anticancer drug development.
Section 1:
Chapter 1: Basic Biostatistics for the Clinical Trialist
Authors: Elizabeth G. Hill and Elizabeth Garrett-Mayer

Chapter 2: Fundamental Concepts in Clinical Pharmacology
Authors: Daniel L. Gustafson and Erica L. Bradshaw-Pierce
Chapter 3: Bioanalytical Methods in Clinical Drug Development
Authors: Walter J. Loos, Peter de Bruijn, Alex Sparreboom
Section 2
Chapter 1: Preclinical Models for Anticancer Drug Development
Author: Edward Sausville

Section 3

Chapter 1: Phase I Clinical Trials with Anticancer Agents
Authors: Stephen Leong, Justin Call, Alex Adjei, Wells Messersmith

Chapter 2: Phase II Clinical Trials with Anticancer Agents
Authors: Hui Gan, J. Jack Lee, Lillian L. Siu

Chapter 3: Phase III Clinical Trials with Anticancer Agents
Authors: Wendy Parulekar and Daniel J. Sargent

Chapter 4: Pharmacokinetic Studies in Early Anticancer Drug Development
Authors: Sharyn D Baker and Alex Sparreboom

Chapter 5: Pharmacodynamic Studies in Early Phase Drug Development
Authors: D. Ross Camidge, Robert C. Doebele and Antonio Jimeno

Chapter 6: Prediction of Antitumor response
Authors: Yu Shyr and Fred R. Hirsch

Chapter 7: Imaging Studies in Anticancer Drug Development
Author: David Mankoff

Section 4

Chapter 1: Role of the US Food and Drug Administration in Cancer Drug Development
Authors: Ann T. Farrell, Ramzi N. Dagher and Richard Pazdur

Section 5

Chapter 1: Early Clinical Trials with Cytotoxic Agents
Authors: M.J.A. de Jonge and Jaap Verweij

Chapter 2: Challenges and Sucesses in Developing Effective Anti-Angiogenic Agents
Authors: Laura QM Chow and S Gail Eckhardt

Chapter 3: Targeted Therapeutics in Cancer Treatment
Authors: Colin D. Weekes and Manuel Hidalgo

Chapter 4: Cancer Chemoprevention
Authors: Christopher H. Lieu, William N. William Jr., Scott M. Lippman

Chapter 5: Combined Modality Therapy in Cancer Management
Authors: David Raben and Kyle Rusthoven

Chapter 6: Cancer Vaccines
Author: Dan Laheru

Chapter 7: Optimizing the Development of Antibodies as Treatment for Cancer
Authors: Craig P Carden, Hendrik-Tobias Arkenau and JS de Bono

Chapter 8: Oligonucleotide Therapeutics
Authors: Cy A Stein, Britta Hoehn, John Rossi
Chapter 9: Anticancer Drug Development in Pediatric Patients
Authors: Lia Gore and Margaret Macy

Chapter 10: Clinical Trials in Special Populations
Authors: S. Percy Ivy, MD; Merrill J. Egorin, MD; Chris H. Takimoto, MD, PhD; and Jeannette Y. Wick, RPh

Section 6:

Chapter 1. NCI Sponsored Clinical Trials
Author: Janet E. Dancey and Andriana Papaconstantinou
A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.